Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19001
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKyzas, P. A.en
dc.contributor.authorStefanou, D.en
dc.contributor.authorBatistatou, A.en
dc.contributor.authorAgnantis, N. J.en
dc.date.accessioned2015-11-24T18:56:12Z-
dc.date.available2015-11-24T18:56:12Z-
dc.identifier.issn0171-5216-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19001-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectCarcinoma, Squamous Cell/*blood supply/*metabolism/mortalityen
dc.subjectFemaleen
dc.subjectHead and Neck Neoplasms/*blood supply/*metabolism/mortalityen
dc.subjectHumansen
dc.subjectImmunohistochemistryen
dc.subjectLymphatic Metastasis/pathologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeoplasm Stagingen
dc.subjectNeovascularization, Pathologicen
dc.subjectPrognosisen
dc.subjectSurvival Analysisen
dc.subjectSurvival Rateen
dc.subjectVascular Endothelial Growth Factor A/*biosynthesisen
dc.titlePrognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinomaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1007/s00432-005-0003-6-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16044346-
heal.identifier.secondaryhttp://www.springerlink.com/content/u421xh216821374h/fulltext.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2005-
heal.abstractPURPOSE: Tumor angiogenesis is crucial for both the growth of the primary tumor and the development of metastases. Among the factors causing tumor angiogenesis, vascular endothelial growth factor (VEGF) is considered as a leading candidate. We aimed to assess the prognostic significance of VEGF and tumor angiogenesis in head and neck squamous cell carcinoma (HNSCC). METHODS: We performed a retrospective study of 69 patients with HNSCC, in order to investigate whether VEGF immunohistochemical expression and tumor angiogenesis correlate with clinicopathological parameters and outcome. Tumor angiogenesis was estimated by determining microvessel density (MVD), and VEGF expression was assessed quantitatively. RESULTS: Vascular endothelial growth factor and MVD correlated statistically significant with the clinical stage, but not with the presence of lymph node metastasis at the time of diagnosis. Tumors located in the oral cavity and larynx more often expressed high VEGF immunostaining compared with tumors located in the lower lip. High VEGF expression was associated with higher clinical stage and worse overall survival in this cohort of patients. CONCLUSIONS: Vascular endothelial growth factor expression may have prognostic significance for patients with HNSCC.en
heal.journalNameJ Cancer Res Clin Oncolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kyzas-2005-Prognostic significa.pdf346.21 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons